Two Sigma Advisers’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-66,600
| Closed | -$5.36M | – | 2518 |
|
|
2025
Q2 | $5.36M | Buy |
+66,600
| New | +$5.14M | 0.01% | 717 |
|
|
2024
Q3 | – | Sell |
-510,600
| Closed | -$35.8M | – | 2426 |
|
|
2024
Q2 | $35.8M | Sell |
510,600
-701,300
| -58% | -$50.1M | 0.08% | 225 |
|
|
2024
Q1 | $89.8M | Sell |
1,211,900
-640,900
| -35% | -$44.7M | 0.21% | 103 |
|
|
2023
Q4 | $123M | Sell |
1,852,800
-177,400
| -9% | -$11.1M | 0.29% | 82 |
|
|
2023
Q3 | $128M | Buy |
2,030,200
+500,500
| +33% | +$31.2M | 0.33% | 74 |
|
|
2023
Q2 | $86.5M | Buy |
1,529,700
+1,278,100
| +508% | +$70.9M | 0.22% | 116 |
|
|
2023
Q1 | $14.6M | Buy |
251,600
+246,900
| +5,253% | +$16.7M | 0.04% | 422 |
|
|
2022
Q4 | $340K | Buy |
+4,700
| New | +$337K | ﹤0.01% | 2024 |
|
|
2021
Q1 | – | Sell |
-182,100
| Closed | -$8.55M | – | 2657 |
|
|
2020
Q4 | $8.55M | Sell |
182,100
-48,400
| -21% | -$2.1M | 0.02% | 619 |
|
|
2020
Q3 | $8.57M | Sell |
230,500
-326,699
| -59% | -$12.4M | 0.02% | 588 |
|
|
2020
Q2 | $20.3M | Buy |
557,199
+267,500
| +92% | +$9.31M | 0.06% | 320 |
|
|
2020
Q1 | $8.86M | Sell |
289,699
-949,400
| -77% | -$42.1M | 0.03% | 523 |
|
|
2019
Q4 | $63.2M | Buy |
1,239,099
+398,700
| +47% | +$19.2M | 0.15% | 165 |
|
|
2019
Q3 | $39.6M | Buy |
840,399
+427,600
| +104% | +$20.4M | 0.1% | 242 |
|
|
2019
Q2 | $20.5M | Buy |
412,799
+305,800
| +286% | +$14.4M | 0.05% | 396 |
|
|
2019
Q1 | $4.55M | Sell |
106,999
-24,900
| -19% | -$1.1M | 0.01% | 868 |
|
|
2018
Q4 | $5.42M | Buy |
131,899
+64,593
| +96% | +$2.77M | 0.01% | 782 |
|
|
2018
Q3 | $3.15M | Buy |
67,306
+57,200
| +566% | +$2.61M | 0.01% | 1016 |
|
|
2018
Q2 | $441K | Buy |
10,106
+2,600
| +35% | +$121K | ﹤0.01% | 1967 |
|
|
2018
Q1 | $344K | Sell |
7,506
-96,500
| -93% | -$4.68M | ﹤0.01% | 1964 |
|
|
2017
Q4 | $5.26M | Sell |
104,006
-160,000
| -61% | -$8.43M | 0.01% | 826 |
|
|
2017
Q3 | $13.7M | Buy |
+264,006
| New | +$12.9M | 0.04% | 475 |
|
|
2017
Q1 | – | Sell |
-21,917
| Closed | -$1.05M | – | 2414 |
|
|
2016
Q4 | $1.05M | Sell |
21,917
-77,731
| -78% | -$3.57M | ﹤0.01% | 1530 |
|
|
2016
Q3 | $3.95M | Sell |
99,648
-157,088
| -61% | -$5.91M | 0.02% | 739 |
|
|
2016
Q2 | $9.11M | Buy |
256,736
+215,424
| +521% | +$8.4M | 0.05% | 392 |
|
|
2016
Q1 | $1.62M | Sell |
41,312
-52,456
| -56% | -$1.96M | 0.01% | 892 |
|
|
2015
Q4 | $4.03M | Buy |
93,768
+61,257
| +188% | +$2.69M | 0.02% | 511 |
|
|
2015
Q3 | $1.37M | Sell |
32,511
-80,608
| -71% | -$3.77M | 0.01% | 871 |
|
|
2015
Q2 | $5.64M | Buy |
113,119
+71,080
| +169% | +$3.37M | 0.04% | 441 |
|
|
2015
Q1 | $1.89M | Sell |
42,039
-256,826
| -86% | -$11.5M | 0.01% | 796 |
|
|
2014
Q4 | $14.4M | Buy |
+298,865
| New | +$14.2M | 0.11% | 224 |
|
|
2014
Q3 | – | Sell |
-77,382
| Closed | -$3.83M | – | 2539 |
|
|
2014
Q2 | $3.83M | Buy |
+77,382
| New | +$3.62M | 0.03% | 556 |
|
|
2014
Q1 | – | Sell |
-818,575
| Closed | -$37.6M | – | 2437 |
|
|
2013
Q4 | $39.3M | Buy |
818,575
+403,695
| +97% | +$18.1M | 0.38% | 51 |
|
|
2013
Q3 | $17.4M | Buy |
+414,880
| New | +$17.9M | 0.21% | 99 |
|
Other funds holding MET
Two Sigma Advisers's MET Position: Q3 2025 in Review
Two Sigma Advisers sold out of MetLife (MET) in Q3 2025, closing a stake of 66,600 shares — an estimated $5.36M sold.
Two Sigma Advisers first reported a position in MET in Q3 2013 and held it in 34 quarters. The position peaked at $128M in Q3 2023. 1,363 funds tracked by Wall St. Rank hold MET as of Q3 2025.
- Two Sigma Advisers reported no remaining MetLife position as of Q3 2025 after selling out during the quarter.
- Two Sigma Advisers sold 66,600 MetLife shares in Q3 2025, an estimated $5.36M.
- Two Sigma Advisers first reported a position in MetLife in Q3 2013 and held it in 34 quarters.
- Two Sigma Advisers's MetLife position peaked at $128M in Q3 2023.
- 1,363 funds tracked by Wall St. Rank held MetLife as of Q3 2025.
Based on Two Sigma Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.